|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
|
|---|---|---|---|---|---|---|
| ASSETS | ||||||
| Current assets | ||||||
| Cash, cash equivalents and restricted cash | ||||||
| Accounts receivable, net of allowance for credit losses of $0.1 million | ||||||
| Inventory | ||||||
| Prepaid expenses and other current assets | ||||||
| Total current assets | ||||||
| Property and equipment, net | ||||||
| Capitalized software, net | ||||||
| Other assets | ||||||
| Total assets | ||||||
| LIABILITIES AND STOCKHOLDERS' DEFICIT | ||||||
| LIABILITIES | ||||||
| Current liabilities | ||||||
| Accounts payable | ||||||
| Accrued expenses and other current liabilities | ||||||
| Convertible debt | ||||||
| Other current debt | ||||||
| Current accrued interest | ||||||
| Deferred revenue, current portion | ||||||
| Total current liabilities | ||||||
| Series P and P2 Preferred Stock liability | ||||||
| Convertible debt, noncurrent | ||||||
| Other noncurrent debt | ||||||
| Noncurrent accrued interest | ||||||
| Deferred revenue, net of current portion | ||||||
| Total liabilities | ||||||
| Stockholders' deficit: | ||||||
| Common stock, $0.00001 par value; 100,000,000 shares authorized as of June 30, 2026; 37,058,212 and 1,294,142 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively | ||||||
| Additional paid-in capital | ||||||
| Accumulated other comprehensive income | ||||||
| Accumulated deficit | ||||||
| Total stockholders' deficit | ||||||
| Total liabilities and stockholders' deficit |
Loading...
